SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013269
Filing Date
2022-08-11
Accepted
2022-08-11 16:06:01
Documents
54
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20220630x10q.htm   iXBRL 10-Q 1241959
2 EX-31.1 armp-20220630xex31d1.htm EX-31.1 15465
3 EX-31.2 armp-20220630xex31d2.htm EX-31.2 15283
4 EX-32.1 armp-20220630xex32d1.htm EX-32.1 8018
5 EX-32.2 armp-20220630xex32d2.htm EX-32.2 8250
6 GRAPHIC armp-20220630x10q001.jpg GRAPHIC 48974
  Complete submission text file 0001558370-22-013269.txt   4654883

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20220630.xsd EX-101.SCH 32748
8 EX-101.CAL armp-20220630_cal.xml EX-101.CAL 32453
9 EX-101.DEF armp-20220630_def.xml EX-101.DEF 145319
10 EX-101.LAB armp-20220630_lab.xml EX-101.LAB 265632
11 EX-101.PRE armp-20220630_pre.xml EX-101.PRE 238600
48 EXTRACTED XBRL INSTANCE DOCUMENT armp-20220630x10q_htm.xml XML 612328
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 221155670
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences